356 related articles for article (PubMed ID: 3011909)
1. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
Nicholson JK; Cross GD; Callaway CS; McDougal JS
J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
[TBL] [Abstract][Full Text] [Related]
2. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
[TBL] [Abstract][Full Text] [Related]
3. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
[TBL] [Abstract][Full Text] [Related]
4. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
Margolick JB; Volkman DJ; Folks TM; Fauci AS
J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
[TBL] [Abstract][Full Text] [Related]
5. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
McDougal JS; Nicholson JK; Cross GD; Cort SP; Kennedy MS; Mawle AC
J Immunol; 1986 Nov; 137(9):2937-44. PubMed ID: 2428879
[TBL] [Abstract][Full Text] [Related]
6. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
[TBL] [Abstract][Full Text] [Related]
7. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
9. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK
Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934
[TBL] [Abstract][Full Text] [Related]
10. Evidence for HTLV-III in T-cells from semen of AIDS patients: expression in primary cell culture, long-term mitogen-stimulated cell cultures, and cocultures with a permissive T-cell line.
Zagury D; Fouchard M; Cheynier R; Bernard J; Cattan A; Salahuddin SZ; Sarin PS
Cancer Res; 1985 Sep; 45(9 Suppl):4595s-4597s. PubMed ID: 2410109
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.
Folks T; Kelly J; Benn S; Kinter A; Justement J; Gold J; Redfield R; Sell KW; Fauci AS
J Immunol; 1986 Jun; 136(11):4049-53. PubMed ID: 2422271
[TBL] [Abstract][Full Text] [Related]
12. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
[TBL] [Abstract][Full Text] [Related]
13. A pathogenic retrovirus (HTLV-III) linked to AIDS.
Broder S; Gallo RC
N Engl J Med; 1984 Nov; 311(20):1292-7. PubMed ID: 6208484
[TBL] [Abstract][Full Text] [Related]
14. Model for studying virus attachment. II. Binding of biotinylated human T cell leukemia virus type I to human blood mononuclear cells potential targets for human T cell leukemia virus type I infection.
Dhawan S; Streicher HZ; Wahl LM; Miller N; Louie AT; Goldfarb IS; Jackson WL; Casali P; Notkins AL
J Immunol; 1991 Jul; 147(1):102-8. PubMed ID: 1646840
[TBL] [Abstract][Full Text] [Related]
15. Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells.
Gomatos PJ; Stamatos NM; Gendelman HE; Fowler A; Hoover DL; Kalter DC; Burke DS; Tramont EC; Meltzer MS
J Immunol; 1990 Jun; 144(11):4183-8. PubMed ID: 2341717
[TBL] [Abstract][Full Text] [Related]
16. Functional modifications of alloreactive T cell clones infected with HTLV-I.
Suciu-Foca N; Rubinstein P; Rohowsky-Kochan C; Cai J; Popovic M; Gallo RC; King DW
J Immunol; 1986 Aug; 137(4):1115-9. PubMed ID: 3016087
[TBL] [Abstract][Full Text] [Related]
17. Experimental infection of rabbits with human T-cell leukemia virus type I.
Akagi T; Takeda I; Oka T; Ohtsuki Y; Yano S; Miyoshi I
Jpn J Cancer Res; 1985 Feb; 76(2):86-94. PubMed ID: 2984072
[TBL] [Abstract][Full Text] [Related]
18. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.
Tenner-Racz K; Racz P; Bofill M; Schulz-Meyer A; Dietrich M; Kern P; Weber J; Pinching AJ; Veronese-Dimarzo F; Popovic M
Am J Pathol; 1986 Apr; 123(1):9-15. PubMed ID: 3008562
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of replication of the AIDS-associated virus HTLV-III/LAV by synthetic D-penicillamine.
Chandra P; Sarin PS
Arzneimittelforschung; 1986 Feb; 36(2):184-6. PubMed ID: 3008768
[TBL] [Abstract][Full Text] [Related]
20. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.
Gartner S; Markovits P; Markovitz DM; Betts RF; Popovic M
JAMA; 1986 Nov; 256(17):2365-71. PubMed ID: 3490587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
